We’re booking a five-fold profit on one of drug stock’s rally to record highs
We’re selling 10 shares of Eli Lilly at roughly $1,269 each. Following Wednesday’s trade, Jim Cramer’s Charitable Trust will own 80 shares of LLY, decreasing its weighting in the portfolio to 2.6% from 2.9%. We’re locking in big gains in pharma giant Eli Lilly as shares jump to a fresh record high on Wednesday. Healthcare is having a standout session, rallying in part on a vicious rotation out of tech and AI stocks into other sectors, as well as a potential breakthrough in an experimental personalized cancer vaccine from Merck and Moderna , which is boosting sentiment in the sector. Merck rose 10% on the vaccine news, while Moderna soared more than 130%. This Lilly trim doesn’t reflect any change in our positive long-term view of the nearly $1.2 trillion market cap company and its position in the obesity market. In fact, on Monday, we noted that total prescriptions for Lilly’s GLP-1 pill, Foundayo, have started to gain ground on the oral version of Novo Nordisk ‘s Wegovy. Eli Lilly shares are up more than 7% for the week and have gained 18% this year. From this sale, we will realize a gain of about 430% on stock purchased in February 2022. LLY YTD mountain Eli Lilly YTD (Jim Cramer’s Charitable Trust is long LLY. See here for a full list of the stocks.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim has talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB. NO SPECIFIC OUTCOME OR PROFIT IS GUARANTEED.
